Losing ground after over 5 years on dutasteride and min
    Minoxidil 8/20/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) over 5 years
    💧 Minoxidil (topical) over 5 years
    💊 Oral Minoxidil (oral) 1.25mg per day
    Microneedling 2 months
    the tone is 😞 negative with not effective results.

    Other terms

    The user is experiencing diffuse hair thinning despite using dutasteride and minoxidil for over five years and is considering adding oral minoxidil, microneedling, and nizoral to their regimen. They are concerned about the effectiveness and side effects of these treatments, especially with an upcoming event.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Minoxidil: A Comprehensive Review

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.
      Experimental and Early Investigational Drugs for Androgenetic Alopecia

      research Experimental and early investigational drugs for androgenetic alopecia

      11 citations , July 2017 in “Expert Opinion on Investigational Drugs”
      This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
      Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia

      research Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia

      June 2026 in “MedScien”
      This study systematically reviewed androgenetic alopecia's clinical features, mechanisms, and treatments, highlighting that current drugs have limitations but emerging therapies and personalized treatment strategies could enhance efficacy and outcomes.
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
      Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia

      research Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia

      January 2026 in “International Society of Hair Restoration Surgery”
      This study reports that a novel multimodal approach, combining tattoo machine–assisted drug delivery of hair loss treatments with oral and topical medications, may enhance hair density and thickness in androgenetic alopecia patients, though larger controlled studies are needed to confirm these early findings.